These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7763341)

  • 1. Inflammation as a pathogenic mechanism in Alzheimer's disease.
    Rogers J
    Arzneimittelforschung; 1995 Mar; 45(3A):439-42. PubMed ID: 7763341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and Alzheimer's disease: relationships between pathogenic mechanisms and clinical expression.
    Eikelenboom P; Rozemuller JM; van Muiswinkel FL
    Exp Neurol; 1998 Nov; 154(1):89-98. PubMed ID: 9875271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
    Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
    Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammatory mechanisms in the pathogenesis of Alzheimer's disease].
    Verbeek MM; Otte-Höller I; Ruiter DJ; de Waal RM
    Tijdschr Gerontol Geriatr; 1997 Oct; 28(5):213-8. PubMed ID: 9526791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
    Walker DG; Lue LF
    J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease.
    Shepherd CE; Gregory GC; Vickers JC; Halliday GM
    Neuropathol Appl Neurobiol; 2005 Oct; 31(5):503-11. PubMed ID: 16150121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and Alzheimer's disease.
    Gupta A; Pansari K
    Int J Clin Pract; 2003; 57(1):36-9. PubMed ID: 12587940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity in Alzheimer's disease: a model for local inflammatory reactions.
    McGeer EG; McGeer PL
    Mol Interv; 2001 Apr; 1(1):22-9. PubMed ID: 14993335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The inflammation in Alzheimer's disease].
    Liao WH; Wang WJ
    Sheng Li Ke Xue Jin Zhan; 2004 Apr; 35(2):181-4. PubMed ID: 15285432
    [No Abstract]   [Full Text] [Related]  

  • 10. The amyloid peptide and its precursor in Alzheimer's disease.
    Octave JN
    Rev Neurosci; 1995; 6(4):287-316. PubMed ID: 8845971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease.
    Carro E; Torres-Aleman I
    Eur J Pharmacol; 2004 Apr; 490(1-3):127-33. PubMed ID: 15094079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inflammatory pathology and the anti-inflammation of saccharide substances in Alzheimer's disease].
    Wang SH; Li J; Geng MY
    Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):67-70. PubMed ID: 15881351
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease.
    Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P
    Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of RAGE in amyloid-beta peptide-mediated pathology in Alzheimer's disease.
    Schmidt AM; Sahagan B; Nelson RB; Selmer J; Rothlein R; Bell JM
    Curr Opin Investig Drugs; 2009 Jul; 10(7):672-80. PubMed ID: 19579173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of oxidant mechanisms in Alzheimer's disease.
    Moreira PI; Smith MA; Zhu X; Santos MS; Oliveira CR; Perry G
    Expert Rev Neurother; 2004 Nov; 4(6):995-1004. PubMed ID: 15853526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory processes in Alzheimer's disease.
    McGeer EG; McGeer PL
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):741-9. PubMed ID: 12921904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune system, amyloid-beta peptide, and Alzheimer's disease.
    Weksler ME; Gouras G; Relkin NR; Szabo P
    Immunol Rev; 2005 Jun; 205():244-56. PubMed ID: 15882358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease.
    Kantarci K
    Expert Rev Neurother; 2005 Sep; 5(5):663-70. PubMed ID: 16162090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and therapeutic vaccination in CNS diseases.
    Weiner HL; Selkoe DJ
    Nature; 2002 Dec 19-26; 420(6917):879-84. PubMed ID: 12490962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.